Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Transactions in relation to share buyback program

Posted on: 26 Jun 15

Acting under its share buyback authorization, the GN Store Nord board of directors initiated a share buyback program on March 11, 2016 in accordance with the provisions of the European Commission’s regulation no. 2273/2003 of December 22, 2003, also referred to as the Safe Harbor rules (company announcement no. 19 of March 11, 2016). 

GN Store Nord’s share-buy-back program is applied without change, but shall going forward be subject to the European Parliament and of the Council’s regulation (EU) no 596/2014 of April 16, 2014, on market abuse and its ancillary acts. 

The share buyback program has been initiated in order to reduce the company’s share capital. Under the share buyback program, which is running from March 11, 2016 and ending no later than March 13, 2017, GN intends to buy back shares for an amount of up to DKK 1,500 million. 

The following transactions have been made under the program in the period January 10, 2017 –January 16, 2017: 


  No. of shares Average purchase price, DKK Transaction Value, DKK
   January 10, 2017 73,126 147.88 10,814,100
   January 11, 2017 26,617 147.52 3,926,580
   January 12, 2017 30,600 147.40 4,510,587
   January 13, 2017 57,000 150.60 8,584,371
   January 16, 2017 36,500 151.53 5,530,736
Accumulated under the program 7,425,069 137.09 1,017,884,115

Following the above transactions GN owns a total of 12,087,721 own shares corresponding to 7.8% of the company’s total share capital. Every Tuesday, GN will announce the number and value of repurchased shares in company announcements to Nasdaq Copenhagen.

For further information please contact: 

Peter Justesen
VP – Investor Relations & Treasury
GN Store Nord A/S
Tel: +45 45 75 87 16


Last updated on: 18/01/2017

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.